Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Imunon, Inc. Director's Dealing 2011

Dec 12, 2011

35124_dirs_2011-12-12_706f1e25-3440-4928-b4b3-b0d6aa04c240.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Celsion CORP (CLSN)
CIK: 0000749647
Period of Report: 2011-12-12

Reporting Person: Borys Nicholas (CMO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2011-12-12 Celsion Corporation Common Stock P 5000 $1.999 Acquired 35687 Direct

Footnotes

F1: The Executive purchased the shares of common stock on the open market.